Abstract 2061P
Background
Patients’ concerns have become more complicated, while the advancements in cancer treatments have improved clinical outcomes. This study aims to comprehensively explore the concerns of cancer patients and to elucidate their interrelationships.
Methods
A fact-finding survey was conducted with 300 cancer patients (male; 127, female; 173) using a 74-item questionnaire. The questionnaire included comprehensive items (rated from 0 [none] to 3 [severe]) related to the concerns of cancer patients. Correlation network analysis was performed to visualize the association between the patients’ concerns. Degree centrality was used to assess network centrality, and the Girvan–Newman algorithm was used to detect communities.
Results
Cancer types were as follows: breast cancer (n=84), gastrointestinal cancer (n=82), urologic cancer (n=52), cholangiopancreatic cancer (n=44), gynecologic cancer (n=20), and others (n=18). The mean overall score was significantly higher in females than in males (30.4 vs. 22.5, p<0.01). The most frequent concerns were physical decline (81.7 %), fatigue (80.5 %), muscle weakness in the limbs (65.9 %). In the overall network, the concerns with the highest centrality score were muscle weakness in the limbs (0.151), nutritional management (0.123) and fatigue (0.082). The network was classified into three communities: 1) physical decline, including 21 items such as muscle weakness, nutritional management, and fatigue; 2) changes in appearance, including 8 items such as pigmentation and hair loss; 3) social support, including 11 items such as employment and finances. The network analysis by gender showed that the highest centered item was sex life (0.123) in men, and depression (0.137) and anxiety (0.110) in women.
Conclusions
This study illustrated that cancer-related fatigue and weakness were the most frequently and numerous interrelated concerns that plagued patients with cancer. Furthermore, they formed a wide-ranging network with other concerns. Our study also showed that the structure of the network differed between the sexes. A multidisciplinary approach may be necessary to comprehensively solve interrelated patient concerns.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
Y. Miura: Financial Interests, Personal, Invited Speaker: Takeda, MSD, Bristol Myers Squibb, Ono Pharmaceutical, Merck BioPharma, Eisai, Astellas Pharma; Financial Interests, Institutional, Local PI: Ono Pharmaceutical, MSD. All other authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06